Stockscreener 앱 받기
1.48
0.68%
0.01
전일 마감가:
$1.47
열려 있는:
$1.48
하루 거래량:
221.78K
Relative Volume:
0.79
시가총액:
$78.43M
수익:
-
순이익/손실:
$-51.47M
주가수익비율:
-1.48
EPS:
-1
순현금흐름:
$-47.50M
1주 성능:
-2.63%
1개월 성능:
+16.54%
6개월 성능:
+4.96%
1년 성능:
-3.27%
1일 변동 폭
$1.465
$1.54
1주일 범위
$1.42
$1.60
52주 변동 폭
$0.81
$1.82
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
명칭
Pmv Pharmaceuticals Inc
전화
(609) 642-6670
주소
400 ALEXANDER PARK DRIVE, PRINCETON
PMVP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.48 | 82.40M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-05-13 | 개시 | Craig Hallum | Buy |
| 2024-04-12 | 개시 | Jefferies | Buy |
| 2023-12-27 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-22 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-08-19 | 개시 | Oppenheimer | Perform |
| 2021-08-02 | 개시 | Guggenheim | Buy |
| 2021-07-29 | 개시 | H.C. Wainwright | Buy |
| 2020-10-20 | 개시 | BofA Securities | Buy |
| 2020-10-20 | 개시 | Cowen | Outperform |
| 2020-10-20 | 개시 | Evercore ISI | Outperform |
| 2020-10-20 | 개시 | Goldman | Neutral |
모두보기
Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스
Visual analytics tools that track PMV Pharmaceuticals Inc. performance2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
RSI and MACD Indicate Shift in PMV Pharmaceuticals Inc. Sentiment2025 Volatility Report & Risk Adjusted Buy and Sell Alerts - beatles.ru
Multi asset correlation models including PMV Pharmaceuticals Inc.2025 Analyst Calls & Free Community Supported Trade Ideas - Newser
Building trade automation scripts for PMV Pharmaceuticals Inc.2025 Fundamental Recap & Verified Short-Term Plans - Newser
How to escape a deep drawdown in PMV Pharmaceuticals Inc.July 2025 Short Interest & Weekly Breakout Watchlists - Newser
Is it time to cut losses on PMV Pharmaceuticals Inc.July 2025 Momentum & Weekly Breakout Stock Alerts - Newser
What MACD signals say about PMV Pharmaceuticals Inc.Earnings Overview Report & Safe Investment Capital Preservation Plans - Newser
Can technical indicators confirm PMV Pharmaceuticals Inc.’s reversalQuarterly Profit Summary & Consistent Growth Equity Picks - Newser
Risk vs reward if holding onto PMV Pharmaceuticals Inc.Trade Ideas & Detailed Earnings Play Alerts - Newser
How high can PMV Pharmaceuticals Inc. stock goQuarterly Profit Report & Daily Profit Focused Screening - Newser
Should you wait for a breakout in PMV Pharmaceuticals Inc.Quarterly Investment Review & Safe Entry Trade Reports - Newser
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionQuarterly Profit Report & Advanced Swing Trade Entry Alerts - Newser
Using data filters to optimize entry into PMV Pharmaceuticals Inc.Buy Signal & Low Risk High Reward Ideas - Newser
PMV Pharmaceuticals Inc. recovery potential after sell offWeekly Trend Recap & Real-Time Volume Spike Alerts - Newser
Can you recover from losses in PMV Pharmaceuticals Inc.July 2025 Institutional & Safe Capital Investment Plans - Newser
Price action breakdown for PMV Pharmaceuticals Inc.2025 Key Highlights & Weekly High Return Stock Opportunities - Newser
Earnings visualization tools for PMV Pharmaceuticals Inc.2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser
What MACD and RSI say about PMV Pharmaceuticals Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser
Is PMV Pharmaceuticals Inc. a candidate for recovery playEarnings Growth Report & Smart Investment Allocation Insights - Newser
Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsEarnings Recap Report & Smart Money Movement Tracker - Newser
Analyzing recovery setups for PMV Pharmaceuticals Inc. investorsJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - Newser
PMV Pharmaceuticals Inc. Tests 50 Day MA After Sharp DeclineAnalyst Upgrade & Weekly Watchlist for Consistent Profits - kangso.co.kr
Top chart patterns to watch in PMV Pharmaceuticals Inc.July 2025 Review & Daily Chart Pattern Signals - Newser
Should you hold or exit PMV Pharmaceuticals Inc. nowTrade Risk Summary & Weekly Top Gainers Trade List - Newser
Is PMV Pharmaceuticals Inc. forming a reversal patternWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Technical signs of recovery in PMV Pharmaceuticals Inc.Portfolio Profit Report & High Yield Equity Trading Tips - Newser
Is PMV Pharmaceuticals Inc. reversing from oversold territoryMarket Growth Review & Free Community Consensus Stock Picks - Newser
Short Term Charts Align With Long Term Uptrend in PMV Pharmaceuticals Inc.July 2025 Trends & Proven Capital Preservation Tips - beatles.ru
What analysts say about PMV Pharmaceuticals Inc. stock outlookQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsAnalyst Upgrade & Weekly Watchlist of Top Performers - Newser
Pmv Pharmaceuticals Inc (PMVP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pmv Pharmaceuticals Inc 주식 (PMVP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Jalota Deepika | Chief Development Officer |
Jul 01 '25 |
Sale |
1.06 |
33,065 |
35,198 |
89,959 |
| Carulli Michael | Chief Financial Officer |
Jul 01 '25 |
Sale |
1.06 |
28,249 |
30,077 |
60,146 |
| Mack David Henry | President and CEO |
Jul 01 '25 |
Sale |
1.06 |
58,411 |
62,179 |
536,133 |
| Mack David Henry | President and CEO |
Dec 03 '24 |
Option Exercise |
0.53 |
91,750 |
48,628 |
534,210 |
| Mack David Henry | President and CEO |
Jan 03 '25 |
Option Exercise |
0.53 |
17,709 |
9,386 |
551,919 |
| Jalota Deepika | Chief Development Officer |
Sep 11 '24 |
Sale |
1.50 |
7,218 |
10,853 |
118,283 |
| Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
0.94%
1.72%
자본화:
|
볼륨(24시간):